General Announcement::Tender Offer & Consent Solicitation-2percent.Resettable Onward Starting Eq-linked Securities due2022

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
16-Apr-2021 12:27:52
Status
New
Announcement Sub Title
Tender Offer & Consent Solicitation-2percent.Resettable Onward Starting Eq-linked Securities due2022
Announcement Reference
SG210416OTHRE0XX
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary and Compliance Officer
Effective Date and Time of the event
16/04/2021 00:00:00
Description (Please provide a detailed description of the event in the box below)
The Issuer wishes to announce today the Settlement of the Offer pursuant to the tender offer and solicitation memorandum dated 19 March 2021.

Attachments

SGX_16042021_Settlement Announcement.pdf
Total size =200K